India's Divi's Labs gains on Q3 profit beat
** Divi's Laboratories DIVI.NS rises 4% to 5,385 rupees
** Pharma co reports 64.5% y/y jump in Q3 consol net profit
to 5.89 bln rupees ($67.6 mln), beating analysts' expectations
of 5.13 bln rupees, per data compiled by LSEG
** Rev from operations up 25% y/y
** Stock top gainer on Nifty Pharma Index .NIPHARM , which
is down 0.3%
** DIVI was trading ~0.2% lower ahead of results
** Stock down 4% YTD vs 9% drop in NIPHARM
($1 = 87.0990 Indian rupees)
(Reporting by Nishit Navin)
((nishit.navin@thomsonreuters.com;))
Recent news on Divi's Laboratories
See all newsDivi's Laboratories and Laurus Labs lead India's record CRDMO growth, Jefferies says
India Stocks: Indian shares inch higher to close at 8-month high as crude oil drops
India's Divi's Laboratories jumps to record high after profit jumps by nearly two thirds
Indian shares muted as markets pause after last week's rally
India Stocks: Indian shares consolidate in Diwali session after seven-day rally